Efficacy and safety of the Betamethasone valerate 0.1% plaster in mild-to-moderate chronic plaque psoriasis: a randomized, parallel-group, active-controlled, phase III study

Naldi, Luigi; Yawalkar, Nikhil; Kaszuba, Andrzej; Ortonne, Jean-Paul; Morelli, Paolo; Rovati, Stefano; Mautone, Giuseppe (2011). Efficacy and safety of the Betamethasone valerate 0.1% plaster in mild-to-moderate chronic plaque psoriasis: a randomized, parallel-group, active-controlled, phase III study. American journal of clinical dermatology, 12(3), pp. 191-201. Heidelberg: Springer 10.2165/11539780-000000000-00000

Full text not available from this repository. (Request a copy)

Corticosteroids are a versatile option for the treatment of mild-to-moderate psoriasis due to their availability in a wide range of potencies and formulations. Occlusion of the corticosteroid is a widely accepted procedure to enhance the penetration of the medication, thereby improving its effectiveness. Betamethasone valerate (BMV) is a moderately potent corticosteroid that is available as a cream, ointment, and lotion. A ready-to-use occlusive dressing, which provides a continuous sustained release of BMV, has been developed for the treatment of psoriasis.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology

UniBE Contributor:

Yawalkar, Nikhil

ISSN:

1175-0561

Publisher:

Springer

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:21

Last Modified:

17 Mar 2015 19:28

Publisher DOI:

10.2165/11539780-000000000-00000

PubMed ID:

21284407

Web of Science ID:

000291277800006

URI:

https://boris.unibe.ch/id/eprint/7087 (FactScience: 212238)

Actions (login required)

Edit item Edit item
Provide Feedback